Last updated 2026-07-20
- Raised Seed round led by aMoon Fund, Mar 2022
Total raised
—
Last: Undisclosed Round 2024-09
Stage
Seed
Founded
2021
Headcount
10
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences
About
Coltac Therapeutics is a biotech startup advancing oncology and non-oncology programs through BOND+ – a proprietary, bacteria-based synthetic screening platform designed for the discovery of novel molecular glues for targeted protein degradation. The company utilizes a multimodal, iterative approach combining deep structural biology expertise and computational approaches to select specific E3-ligase libraries for expression in a proprietary high-throughput E. Coli-based positive selection screening system. Molecular Glue drug candidates are then discovered based on their ability to enhance binding of an E3 ligase to the target protein.
Funding history · 1 round · — total
2022-03
Seed
Undisclosed
★ aMoon Fund
Q&A
- What is Coltac Therapeutics' primary focus?
- Coltac Therapeutics is a preclinical pharmaceutical company developing a bacteria-based synthetic positive selection screening system for discovering molecular glues.
- When was Coltac Therapeutics founded?
- Coltac Therapeutics was founded in January 2022.
- How many employees does Coltac Therapeutics have?
- Coltac Therapeutics has 1-10 employees.
- What is the total amount of funding Coltac Therapeutics has raised to date?
- Coltac Therapeutics has raised a total of $5,000,000 USD.
- When was Coltac Therapeutics' most recent funding round and who were the lead investors?
- Coltac Therapeutics' most recent funding round was in September 2024, with aMoon Fund as a lead investor.
- What is Coltac Therapeutics' current funding stage?
- Coltac Therapeutics is currently in the Seed funding stage.
- In which sector does Coltac Therapeutics primarily operate?
- Coltac Therapeutics operates primarily in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Where is Coltac Therapeutics headquartered?
- Coltac Therapeutics is headquartered in Ra'anana, Israel.
Team · 1
Gali Prag
Founder · Co-founder & board member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcare
Business model
B2B
Tags
oncologybiopharmaceuticalbiotechnologydrug-discoveryproteins
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | coltactx.com |
|---|
Identifiers & details
| Founded | 2021 |
|---|---|
| Employees (exact) | 10 |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516542305 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-01-20 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 1 — charge (1) |
| Registered address | ירושלים 34 רעננה |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-31 | רישום שעבוד |